360
Participants
Start Date
August 31, 2009
Primary Completion Date
September 30, 2011
Study Completion Date
November 30, 2011
dutogliptin
100 mg QD
dutogliptin
200 mg QD
placebo
sitagliptin
25 mg QD
sitagliptin
50 mg QD
Phenomix Investigational Site 115, Tempe
Phenomix Investigational Site 121, Long Beach
Phenomix Investigational Site 110, Lynwood
Phenomix Investigational Site 118, Lynwood
Phenomix Investigational Site 119, Orange
Phenomix Investigational Site 109, Palm Springs
Phenomix Investigational Site 122, Whittier
Phenomix Investigational Site 112, Lauderdale Lakes
Phenomix Investigational Site 104, Ocala
Phenomix Investigational Site 116, Pembroke Pines
Phenomix Investigational Site 101, Augusta
Phenomix Investigational Site 117, Honolulu
Phenomix Investigational Site 102, Baton Rouge
Phenomix Investigational Site 100, Rockville
Phenomix Investigational Site 125, Rockville
Phenomix Investigational Site 114, Springfield Gardens
Phenomix Investigational Site 120, Winston-Salem
Phenomix Investigational Site 107, Columbia
Phenomix Investigational Site 111, Nashville
Phenomix Investigational Site 103, Fort Worth
Phenomix Investigational Site 106, Houston
Phenomix Investigational Site 108, San Antonio
Phenomix Investigational Site 113, Alexandria
Phenomix Investigational Site 208, Kemerovo
Phenomix Investigational Site 203, Moscow
Phenomix Investigational Site 204, Moscow
Phenomix Investigational Site 209, Moscow
Phenomix Investigational Site 211, Moscow
Phenomix Investigational Site 205, Novosibirsk
Phenomix Investigational Site 207, Perm
Phenomix Investigational Site 206, Petrozavodsk
Phenomix Investigational Site 200, Saint Petersburg
Phenomix Investigational Site 201, Saint Petersburg
Phenomix Investigational Site 210, Saint Petersburg
Phenomix Investigational Site 212, Saint Petersburg
Phenomix Investigational Site 213, Saint Petersburg
Phenomix Investigational Site 304, Chernivtsi
Phenomix Investigational Site 300, Kyiv
Phenomix Investigational Site 301, Kyiv
Phenomix Investigational Site 306, Kyiv
Phenomix Investigational Site 302, Odesa
Phenomix Investigational Site 303, Vinnytsa
Phenomix Investigational Site 307, Zaporizhzhya
Lead Sponsor
Collaborators (1)
Forest Laboratories
INDUSTRY
Phenomix
INDUSTRY